COVID 19 – What are the imperatives and implications for Financial Markets
An early assessment of the COVID-19 outbreak, its policy responses, and the near-term implications for economic activity and equity markets, with a focus on market strategy during heightened uncertainty.
Asset Class Outlook – Equity
Equities are expected to deliver ~15% CAGR over the coming years, supported by India’s catch-up growth phase and favourable policy environment.
Why India’s Growth Story Remains Intact?
A comparative analysis of the 1998 US sanctions and the 2025 US tariffs, highlighting India’s structural resilience and long-term growth trajectory.
Pharma & Healthcare Sector – Time to Overweight!
A sector-level assessment outlining why Pharma & Healthcare in India offers an attractive overweight opportunity after two years of consolidation and multiple derating.
US Tech Sector – Outlook
A forward-looking assessment of the US tech sector driven by inflation trends, Fed policy, earnings guidance from mega-tech companies, and valuation resets across software and semiconductor segments.
Pharma Sector : Attractive Medium to Long Term Opportunity!
An assessment of medium-to-long-term opportunities across the Pharma sector, with a broader strategic view on IT, FMCG, Auto, and PSU sectors amid evolving valuation and growth dynamics.
Navigating The Choppy Equity Markets
An assessment of Indian equity markets amid COVID-19 uncertainty, outlining market ranges, recovery expectations, asset allocation strategy, and key macro variables influencing outcomes.
WealthSpring’s GDP Forecast – People will soon come to grips with reality
WealthSpring outlines its early and contrarian view on India’s GDP contraction in FY21, highlighting how equity markets had already begun discounting a sharp economic slowdown well ahead of consensus expectations.
Paradox posed by US Financial Markets
Despite a once-in-a-century pandemic severely impairing real economic activity, US equity markets have rebounded sharply—raising fundamental questions about market assumptions, policy effectiveness, and expectations of a medical breakthrough.
Markets – What should we do!
A tactical market view amid the COVID-19 sell-off, highlighting valuation comfort in Indian equities, global risks from the pandemic, and a disciplined accumulation strategy.